Category : Healthcare and Pharmaceuticals | Published at : January-2019 | Delivery Format : PDF | Status: Published | Pages : 160
Introduction
The global Hand-held surgical instruments market size is expected to around USD 6.55 billion by 2026, this market is foreseen to develop with 7.3% CAGR during the forecast time period.
Market Dynamics
The market is foreseen to be driven by ascend in number of surgeries being performed and increment in commonness of perpetual ailments. Likewise, ascend in number of street and different mishaps comprehensively is adding to appeal for these careful instruments.
Rising pervasiveness of constant illnesses, for example, neurological, infectious, cardiovascular, and urological ailments is relied upon to drive the market.
As per the World Federation of Neurology, 12 out of each 100 patients kick the bucket because of neurological illnesses. Cardiovascular sicknesses are additionally prompting an expansion in number of heart medical procedures. For example, coronary supply route sidestep uniting (CABG) is a typical medical procedure to unblock the coronary conduit. Expanding weight of these ailments has prompted development of treatments and medicines, accordingly prompting ascend sought after for handheld careful instruments.
Market Insights
Developing geriatric populace is one of the central point driving the market in Asia Pacific. As per the National Census report of 2015, almost 26.7% of the all-out populace in Japan is matured 65 years or more, prompting high commonness of incessant infections in the nation. The hand-held careful instruments market can be classified based on application into neurosurgery, cardiovascular, orthopedic, plastic and reconstructive medical procedure, obstetrics and gynecology, and others. The others section, which incorporates general medical procedure, urologic medical procedure, thoracic medical procedure, wound conclusion, and microvascular medical procedures, held the biggest income share in 2017. Ascend in number of general medical procedures is a central point driving fragment development.
Market Segmentation
Market By Application
- Neurosurgery
- Cardiovascular
- Orthopedic
- Plastic & Reconstructive Surgery
- Obstetrics &Gynecology
- Others
Market By Product
- Forceps
- Retractors
- Dilators
- Graspers
- Scalpels
- Others
Market By End-user
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
Market By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- Rest of Asia-Pacific
- Latin America
- Brazil
- Chile
- Rest of Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- Rest of MEA
Regional Insights
In 2017, North America commanded the market, powered by expanding rate of ceaseless ailments, for example, cardiovascular illnesses, neurological infections, cancer, diabetes, and immune system sicknesses. As per the World Bank, in 2015, 4,511 medical procedures for each 100,000 people were performed in U.S., a factor that has worked for the provincial market. As indicated by WHO, the weight of non-transmittable illnesses is most elevated in Europe area and is required to develop at a high rate in future. As indicated by the European Road Safety Observatory Annual Accident Report 2017, more than 1,079,720 street wounds were accounted for in 2015. With developing number of surgeries, requirement for careful instruments is ascending in the region.
Developing geriatric populace is one of the central point driving the market in Asia Pacific. As per the National Census report of 2015, almost 26.7% of the all-out populace in Japan is matured 65 years or more, prompting high commonness of incessant infections in the nation.
Market Participants
Few of the main player present in the global Hand-held surgical instruments market are Aspen Surgical, Zimmer Biomet Holdings; Thompson Surgical Instruments Inc.; B. Braun Melsungen AG; Johnson & Johnson; Becton, Medtronic; CooperSurgical Inc.; Dickinson and Company; Smith & Nephew and Integra Life Sciences Corporation.
